Achillion Pharmaceuticals Inc. Bookmark and Share

ArticleDateSource
Form 4 ACHILLION PHARMACEUTICAL For: Jan 13 Filed by: KISHBAUCH MICHAEL DJanuary 14, 2012Pharmaceutical - Moreover
FDA grants fast track status to Achillion ACH-1625 drug - Pharmaceutical Business ReviewJanuary 05, 2012Pharmaceutical - Moreover
Achillion Pharmaceuticals, Inc. Release: ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C January 04, 2012BioSpace - Breaking News
Achillion hepatitis drug gets faster FDA reviewJanuary 04, 2012Health News - CNBC
Form 8-K ACHILLION PHARMACEUTICAL For: Dec 12December 16, 2011Pharmaceutical - Moreover
Achillion to Present at the 23rd Annual Piper Jaffray Health Care ConferenceNovember 21, 2011Pharmaceutical - Moreover
Achillion Pharma CEO talks up sale amid Hep C trials November 18, 2011FierceBiotech
Achillion to Present at the JMP Healthcare ConferenceSeptember 22, 2011Pharmaceutical - Moreover
Analyst sees promising future for Achillion PharmaSeptember 08, 2011Health News - CNBC
Achillion Pharmaceuticals, Inc. Reports Second Quarter and Six MonthAugust 10, 2011Biotechnology - Moreover
Long-Term Positives En-Route, Review of Healthcare Reform - Equity Research on Achillion Pharmaceuticals, Inc. and Health Management Associates, Inc.July 22, 2011Marketwire - Pharma and Biotech
Form 4 ACHILLION PHARMACEUTICAL For: Jul 13 Filed by: FISHERMAN JASON SJuly 15, 2011Pharmaceutical - Moreover
Form 4 ACHILLION PHARMACEUTICAL For: Jul 08 Filed by: FISHERMAN JASON SJuly 12, 2011Pharmaceutical - Moreover
Achillion expects to raise $53M in stock offeringJune 22, 2011Health News - CNBC
Achillion Pharmaceuticals, Inc. Added to the NASDAQ Biotechnology Index (NBI)May 18, 2011Biotechnology - Moreover
Achillion Added to the NASDAQ Biotechnology IndexMay 18, 2011Biotechnology - Moreover
Achillion Added to the NASDAQ Biotechnology Index (NBI)May 18, 2011Biotechnology - Moreover
Achillion 1Q loss widens on higher costsMay 04, 2011Health News - CNBC
Achillion to Present at Upcoming Investor ConferencesApril 08, 2011Pharmaceutical - Moreover
Achillion Pharmaceuticals, Inc. Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C March 30, 2011BioSpace - Breaking News
Achillion Pharmaceuticals (ACHN) Reports Positive Phase 2a Clinical Results for Hepatitis C TreatmentMarch 30, 2011Pharmaceutical - Moreover
Achillion shares spiked on positive trial resultsMarch 30, 2011Health News - CNBC
Achillion Pharmaceuticals, Inc. Reports 2010 Fourth Quarter and Year-End Financial Results March 02, 2011BioSpace - Breaking News
Achillion cuts 4Q loss, posts more grant revenueMarch 02, 2011Health News - CNBC
Form 4 ACHILLION PHARMACEUTICAL For: Dec 16 Filed by: Simon NicholasDecember 20, 2010Pharmaceutical - Moreover
Form 4 ACHILLION PHARMACEUTICAL For: Oct 06 Filed by: SCHOEMAKER KATHLEEN KOctober 08, 2010Pharmaceutical - Moreover
Form 4 ACHILLION PHARMACEUTICAL For: Oct 06 Filed by: DOVEY BRIAN HOctober 08, 2010Pharmaceutical - Moreover
Venture groups snap up $50M block of Achillion sharesAugust 19, 2010FierceBiotech
Achillion says it will raise $50M from stock saleAugust 19, 2010Health News - CNBC
Achillion Pharmaceuticals, Inc. Finds $50.1M August 19, 2010BioSpace
Achillion Pharma Finds $50.1MAugust 18, 2010Xconomy Life Sciences
Achillion Pharma Soars on Positive Test ResultsMay 12, 2010Health News - Fox Business
Achillion Pharmaceuticals, Inc. Announces Positive Once-Daily Dosing Results With ACH-1625 to Treat Hepatitis C May 12, 2010BioSpace - Breaking News
Achillion shares spike on promising hep C dataMay 12, 2010FierceBiotech
Achillion Pharmaceuticals posts narrower 1Q lossMay 10, 2010Health News - CNBC
Achillion Pharmaceuticals, Inc. Announces Award of National Institutes of Health (NIH) Grant to Study Unique Antibacterial Compound Series March 18, 2010BioSpace - Breaking News
Achillion Wins SBIR Grant to Evaluate Preclinical Compounds against Drug-Resistant TBMarch 18, 2010GEN News Highlights
Form 8-K ACHILLION PHARMACEUTICAL For: Mar 09March 12, 2010Pharmaceutical - Moreover
Achillion Pharmaceuticals, Inc. Reports 2009 Fourth Quarter and Year-End Financial Results March 12, 2010BioSpace - Breaking News
Form 10-K ACHILLION PHARMACEUTICAL For: Dec 31March 11, 2010Pharmaceutical - Moreover
Form 8-K ACHILLION PHARMACEUTICAL For: Feb 26March 04, 2010Pharmaceutical - Moreover
Achillion Pharmaceuticals, Inc. Reports More Positive Data from HIV Study February 17, 2010BioSpace
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: Bear Stearns Companies LLCFebruary 16, 2010Pharmaceutical - Moreover
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: SCHRODER VENTURE MANAGERS LTDFebruary 16, 2010Pharmaceutical - Moreover
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ProQuest Investments III, L.P.February 09, 2010Pharmaceutical - Moreover
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ATLAS VENTURE FUND V LPFebruary 05, 2010Pharmaceutical - Moreover
Achillion Pharmaceuticals, Inc. Announces Closing of Underwriters' Over-Allotment Option February 03, 2010BioSpace - Breaking News
Achillion rises on hepatitis/HIV drug pactFebruary 02, 2010Health News - CNBC
Achillion signs licensing agreement with GCA TherapeuticsFebruary 02, 2010Pharmaceutical - Moreover
Achillion Announces License Agreement for Elvucitabine Development in ChinaFebruary 01, 2010Pharmaceutical - Moreover
Achillion Pharmaceuticals (ACHN) Annouinces License Agreement for Elvucitabine Development in ChinaFebruary 01, 2010Pharmaceutical - Moreover
Drug stocks mixed; Curis and Achillion tumbleJanuary 22, 2010Biotechnology - Moreover
Achillion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock January 22, 2010BioSpace - Breaking News
Achillion Pharmaceuticals, Inc. Prices $21.4 Million Public Offering of Common Stock January 22, 2010BioSpace - Breaking News
Achillion Pharmaceuticals, Inc. Announces Additional Positive Phase 1b Data With ACH-1625 to Treat Hepatitis C January 11, 2010BioSpace - Breaking News
Drug Stocks Rise; Achillion RalliesJanuary 11, 2010Health News - Fox Business
Achillion Pharmaceuticals, Inc. Announces Promising Hepatitis C Drug Data; Stock Up 60.93% @ 10:28AM ET December 16, 2009BioSpace
Achillion shares rocket up on promising hep C dataDecember 16, 2009FierceBiotech
Achillion Pharmaceuticals, Inc. Announces Promising Hepatitis C Drug Data December 16, 2009BioSpace



View all the latest news